Mueller H, Kassack MU, Wiese M. Comparison of the usefulness of the MTT, ATP, and calcein assays to predict the potency
of cytotoxic agents in various human cancer cell lines.
The targeted drug delivery appears to be a very promising strategy for controlling the biodistribution
of the cytotoxic agent only on malignant tissues by linking it to tumor - targeting moiety.
Not exact matches
No targeted therapy has been approved for noninflammatory and inflammatory triple - negative breast cancer tumors, and the standard
of therapy for these tumors is a combination
of conventional
cytotoxic chemotherapeutic
agents.
«These new results are significant because they represent the discovery
of a number
of more potent variations
of the natural product as
cytotoxic agents against cancer cells,» Nicolaou said.
These
agents will possibly increase the
cytotoxic action
of MDR - related drugs by preventing the extrusion
of anticancer drugs from the target cells.
Exocytic responses
of single leukaemic human
cytotoxic T lymphocytes stimulated by
agents that bypass the T cell receptor.
Immunologic checkpoint blockade with anti —
cytotoxic T - lymphocyte — associated antigen 4 (CTLA - 4) or anti — programmed death 1 (PD - 1) / programmed death ligand 1 (PD - L1)
agents seems to have some degree
of clinical efficacy in advanced mucosal melanoma, although data are limited to smaller retrospective series or subset analyses
of prospective trials.
Chemotherapy for MDS patients involves the use
of medicines that kill cells cancer cells called
cytotoxic agents.
This study illustrates the potential benefits
of using GHRH antagonists for the treatment
of cancers that are highly resistant to
cytotoxic agents such as doxorubicin.
The control
of these conditions often involves the long - term use
of corticosteroids and other drugs such as immunosuppressive or
cytotoxic agents.